SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-007076
Filing Date
2015-02-05
Accepted
2015-02-05 17:07:54
Documents
2
Period of Report
2015-02-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-3857_18k.htm 8-K 24122
2 EX-10.1 a15-3857_1ex10d1.htm EX-10.1 24296
  Complete submission text file 0001104659-15-007076.txt   49834
Mailing Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 15581007
SIC: 2834 Pharmaceutical Preparations